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Table 2. The comparison of left atrial diameters and functions between
patients with and without interatrial block and P-terminal force
Interatrial block
(+) (n¼42)
Interatrial block
(-) (n¼26) P-value
Reservoir function(%) 35.56.5 46.28.9 <0.001
Conduit function (%) 15.83.5 21.25.1 <0.001
Pump function (%) 31.44.6 39.47.2 <0.001
Left atrial diameter (mm) 46.85.6 38.43.9 <0.001
P-terminal force
(+) (n¼45)
P-terminal force
(-) (n¼23)
Reservoir function(%) 37.25.9 44.86.7 <0.001
Conduit function (%) 15.93.7 20.75.2 <0.001
Pump function (%) 32.55.2 39.87.1 <0.001
Left atrial diameter (mm) 45.55.7 39.55.5 <0.001
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Background: The Apolipoprotein B (Apo B) gene mutations characterized by
elevated low density lipoprotein cholesterol levels and premature coronary artery
disease and/or myocardial infarction. The Apo B gene is located on chromosome 2.
The Apo B gene mutation is a single base substitution (G to A) at nucleotide 10708 of
the apo B gene. This mutation gives rise to the substitution of arginine for glutamine at
residue 3500 of the apo B-100 molecule, within a region containing the putative
receptor binding domain. Although various gene polymorphsims have been studied in
patients with nonvalvuler AF who have had a stroke, Apo B gene polymorphisms
have not been studied previously. We investigated relationship between R3500Q
mutation of the Apo B gene and nonvalvular AF with Ischemic Stroke.
Methods: The Apo B R3500Q gene mutation was analysed in 70 patients with
nonvalvuler AF who have had a stroke and 70 healthy individuals with no docu-
mented episode of AF matched for age, race and sex. The Apo B R3500Q gene
mutation was identiﬁed by polymerase chain reaction (PCR) method. Distribution of
the Apo B R3500Q gene alles (allel G, allel A) and genotypes (Normal (GG) geno-
type, heterozygous (GA) or homozygous (AA) mutant genotype) were determined in
study population. Demographic characteristics and risk factors for AF and stroke were
evaluated in the study groups.
Results: There was no signiﬁcant difference with respect to age and gender between
groups. There was no statistical difference in genotype distribution among the groups.
The genotype distribution in nonvalvuler AF who have had a stroke group was as
follows: normal genotype (GG) frequency was 67 (95.7%) and heterozygous mutant
genotype (GA) frequency was 3 (4.3%). The genotype distribution in control group
was as follows: normal genotype (GG) frequency was 68 (97.1%) and heterozygous
genotype (GA) frequency was 2 (2.9%). Homozygous genotype (AA) was not
detected in both groups. There was no statistically signiﬁcant difference betwen
groups in genotype distributions.
Conclusıons: Our results suggest that the Apo B R3500Q gene mutation appears not
to be associated with nonvalvular AF with ischemic stroke in Turkish population.
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Purpose: Lichen planus is a chronic, inﬂammatory, and autoimmune mucocutaneus
disease. There has been recent research emphasis on the strong association between
inﬂammation both P-wave dispersion and dyslipidemia. The differences between the
maximum and the minimum P-wave duration on electrocardiogram are deﬁned as P-
wave dispersion. Prolongation of P-wave dispersion has been demonstrated to be an
independent risk factor for the development of atrial ﬁbrillation. The aim of this the
study was to investigate P-wave dispersion in patients with lichen planus.JACC Vol 62/18/Suppl C j October 26–29, 2013 j TSC Abstracts/POSTMethods: Fifty-eight patients with lichen planus and 37 age and sex-matched, healthy
controls were included in this study. We obtained electrocardiographic recordings
from all participants and used them to calculate P-wave variables. We also assessed
high-sensitive C-reactive proteins that an inﬂammatory marker and the lipid levels for
each group. Results were reported as means  standard deviations and percentages.
Results: P-wave dispersionwere signiﬁcantly higher in lichen planus patients than in the
control group (39.912.9ms, versus 32.411.8ms, p¼0.005, respectively). Also, high-
sensitive C-reactive proteins (3.52.6, versus 1.71.1, p<0.001), LDL-cholesterol
(129.631.7, versus 96.833.6, p<0.001) and, triglyceride (169.293.6, versus
110.552.7, p¼0.001)levels were signiﬁcantly higher in patients with lichen planus,
compared to controls. There was a signiﬁcant, positive correlation between high-
sensitive C-reactive proteins and P-wave dispersion (r¼0.549, p<0.001) in lichen pla-
nus patients.
Conclusıons: P-wave dispersion increased on surface electrocardiographic measure-
ments in lichen planus patients. This result may be important in early detection of
subclinical cardiac involvement. Increased P-wave dispersion should be considered, in
terms of tendency to atrial ﬁbrillation, in these patients.ERS C149
Table II. Echocardiographic measurements of study population.
LP patients
(n¼58)
Control group
(n¼37) P
LVEDD (mm) 45.94.3 47.03.6 NS
LVESD (mm) 26.34.9 28.34.1 NS
LV ejection fraction (%) 675.1 683.0 NS
LA diameter (mm) 33.84.4 33.93.8 NS
EDT (ms) 218.146.1 208.234.9 NS
IVRT (ms) 88.622.6 79.713.9 NS
LVESD: Left ventricle end-systolic diameter, LVEDD: Left ventricle end-diastolic diameter, LV:
Left ventricle, LA: Left atrial, E: The peak mitral valve ﬂow velocity during the early rapid ﬁlling
phase, A: The peak mitral valve ﬂow velocity during atrial contraction, EDT: Deceleration time
of early phase of mitral valve ﬂow; IVRT ¼ Isovolumetric relaxation time.
Table 1
Variables OR p 95%CI
Age (years) 1,07 <0,001 1,04-1,09
Gender (male) 1,05 0,87 0,57-1,93
CAD 3,26 0,001 1,58-6,75
HT 1,03 0,91 0,57-1,84
DM 1,44 0,23 0,78-2,65
GFR(ml/min) 1,01 0,62 0,98-1,02
BMI (kg/m2) 0,96 0,30 0,91-1,03
SUA(mg/dl) 1,30 0,001 1,10-1,52
CAD: Coronary artery disease, GFR: Glomerular ﬁltration rate, BMI: Body mass index, OR: Odds
ratio, CI: Conﬁdence interval, SUA: Serum uric acid
Table I. Demographic characteristics of study population.
LP patients
(n¼58)
Control group
(n¼37) P
Age (years) 43.4  14.5 39.311.6 NS
Male (n,%) 28 (48.3%) 19 (51%) NS
Smoking (n,%) 22(%37.9) 10(27%) NS
BMI (kg/m2) 26.73.7 25.22.8 NS
Fasting glucose (mg/dL) 85.97.74 86.38.8 NS
LDL cholesterol (mg/dL) 129.631.7 96.833.6 <0.001
Trigliserides (mg/dL) 169.293.6 110.552.7 0.001
hs-CRP (mg/L) 3.52.6 1.71.1 <0.001
Systolic BP (mmHg) 1288.5 12312.9 NS
Diastolic BP (mmHg) 76.511.5 787.8 NS
BMI: body mass index, BP: blood pressure, HR: heart rate, hsCRP: high-sensitivity C-reactive
protein, LDL: low-density lipoprotein, HDL: high-density lipoprotein, NS: statistically non-
signiﬁcant
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Purpose: Serum uric acid (SUA) has antioxidant properties and has recently been
associated with many cardiovascular (CV) risk factors. The aim of the present study
was to determine the relationship between SUA and prevalence of AF in a population
based data.
Methods: Surface ECGs were obtained from the HAPPY (Heart Failure Prevalence
and Predictors in Turkey) study including randomly selected 4650 subjects 35 years
with laboratory and clinical data from Turkey. After exclusion of subjects with
missing data; 3973 subjects ([meanSD]age, 5211, [range]35-100 years) were
enrolled in the study (female n [overall%]:2251 [56,7%]). All ECGs were interpreted
manually by two experienced cardiologists for the presence of AF.
Results: The prevalence of AF was 1,6% in Turkish population with a signiﬁcant
incline in the older age groups (35-54, 55-64, 65 [years]; 0,6%, 1,9%, 4,2%
respectively, p<0,001) and more prevalent in men (2,1% vs 1,2% p<0,001). Mean
SUA was (meanSEM) 4,60,02 mg/dl in the overall population being signiﬁcantly
higher in men (5,20,03 vs 4,10,02 p<0,001). SUA was signiﬁcantly higher in
subjects with AF (5,40,17 vs 4,60,02 p<0,001). In multivariate logistic regression
analyses, SUA level was an independent predictor of AF in general Turkish pop-
ulation after adjusting for age, gender, hypertension, coronary artery disease, diabetes,
glomerular ﬁltration rate and body mass index (OR: 1,30 CI: 1,10-1,52 p¼0,001)
(Table-1).
Conclusıons: SUA was signiﬁcantly associated with crude AF prevalence in Turkish
population suggesting a link between SUA and AF as well as various traditional CV
risk factors affecting the pathogenesis of AF.C150 JACC VoPP-175
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Objectıve: Hunger strike is a common type of protest that is widely seen in prisons.
Long term starvation causes many health problems. In this study electrocardiograms
(ECG) of detainees and convicts proceeding on hunger strike are compared with those
taken after strike.
Methods: Between September 2012-November 2012, 81 male (mean age 419.4
years) detainees and convicts on hunger strike approximately 459.6 days long were
conducted in this study. 12-lead ECGs obtained on the last day of the starvation and 2
months after it were scanned, transferred to high-resolution computer screens and
evaluated.
Results: Avarage 63.7 kg loss was seen in 81 patients on hunger strike. In 81 ECGs
evaluated on the last day of the starvation 16 (19.7%) early repolarization (inferior:10,
lateral:5, inferolateral:1) and in those taken two months after the strike 4 (4.9%) early
repolarization (inferior:3, lateral:1) (p<0.001) were deteremined. Signiﬁcant differ-
ence was found in PR (15775 ms vs. 15323 ms, p:0.035) interval and QRS
(9573 vs. 9211, p:0.001) duration whereas it could not be done in heart rate
(p:0.068), cQT (p:0.325), QT dispertion (p:0.245) and in PR dispertion (p:0.812).
Conclusıon: Previously, ER has been thought a sign of good health due to its being
seen prevalent in athletes, younger persons, and at slower heart rates. Nevertheless,
numerous recent reports have suggested a relationship between ER and an increased
risk for arrhythmic death and idiopathic ventricular ﬁbrillation. We present for the ﬁrst
time that long term starvation is related with ER, therefore hunger strike should be
included in the list of conditions associated with it.
PP-176
The Effects of Nebivolol on QT Duration and Dispersion in Patients with
Coronary Slow Flow
Musa S¸ahin1, Hakkı S¸ims¸ek1, Aytac Akyol2, Serkan Akdag1, Mehmet Ata Akil3,
Hakan Aksoy4, Adnan Dogan4, Hasan Ali Gumrukcuoglu1
1Yuzunci Yil University, Faculty of Medicine, Cardiology Department, Van, 2Van
Research and Education Hospital, Cardiology Department, Van, 3Dicle University,
Faculty of Medicine, Cardiology Department, Diyarbakır, 4Osmaniye State Hospital,
Cardiology Department, Osmaniye, Turkey
The coronary slow-ﬂow (CSF) is an angiographic phenomenon characterized by
delayed opaciﬁcation of vessels in the absence of any evidence of obstructive
epicardial coronary disease. QT interval dispersion (QTD) reﬂects regional variations
in ventricular repolarization and cardiac electrical instability and has been reported to
be longer in patients with CSF. The purpose of this study was to examine the effect of
nebivolol on QTD in patients with CSF.
The study population included 67patients with angiographically proven normal
coronary arteries and CSF and 38 patients with angiographically proven normal
coronary arteries without associated CSF. The patients were evaluated with 12-leads
electrocardiography and echocardiography before and three months after treatment
with nebivolol.
Compared to control group QTcmax and QTcD were signiﬁcantly longer in patients
with CSF (p¼0.036, 0,019 respectively) (Table 1, Fig.1). QTcD signiﬁcantly corre-
lated with the presence of CSF (r¼0.496, p<0.001). QTcmax (p¼0.027), QTcD
(p¼0,002), blood pressure (p¼0,001) and heart rate (p<0,001) values signiﬁcantly
decreased after treatment with nebivolol
In conclusion, coronary slow ﬂow is associated with increased QT dispersion.
Nebivolol reduced increased QT dispersion in patients with CSF after three months.l 62/18/Suppl C j October 26–29, 2013 j TSC Abstracts/POSTERS
